A pilot study of IL-1 inhibition by anakinra in acute gout

Arthritis Research and Therapy

Volumn 9, Issue , 2007, Pages

  So, Alexander ^a   De Smedt, Thibaut ^b   Revaz, Sylvie ^a   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Apoxis SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIINFLAMMATORY AGENT; COLCHICINE; CORTICOSTEROID; CREATININE; DICLOFENAC; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 1 ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RASBURICASE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ANTIBODY; URATE OXIDASE; URIC ACID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL PAIN; GOUT; HUMAN; HYPERURICEMIA; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; OPEN STUDY; PILOT STUDY; URIC ACID BLOOD LEVEL; ANIMAL; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; PERITONITIS;

ADULT; AGED; ANIMALS; ARTHRITIS, GOUTY; CHEMOTAXIS, LEUKOCYTE; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MICE; MIDDLE AGED; PERITONITIS; PILOT PROJECTS; URIC ACID;

EID: 34047174085     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2143     Document Type: Article

References (17)

1. Saag KG Choi H Epidemiology, risk factors, and lifestyle modifications for gout Arthritis Res Ther 2006 8 S2 10.1186/ar1907 16820041
2. di Giovine FS Malawista SE Thornton E Duff GW Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution J Clin Invest 1991 87 1375-1381 295177 2010550
3. Malawista SE Duff GW Atkins E Cheung HS McCarty DJ Crystal-induced endogenous pyrogen production. A further look at gouty inflammation Arthritis Rheum 1985 28 1039-1046 10.1002/art.1780280911 2994686
4. Di Giovine FS Malawista SE Nuki G Duff GW Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1 J Immunol 1987 138 3213-3218 3033070
5. Liu-Bryan R Scott P Sydlaske A Rose DM Terkeltaub R Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation Arthritis Rheum 2005 52 2936-2946 10.1002/ art.21238 16142712
6. Martinon F Petrilli V Mayor A Tardivel A Tschopp J Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 2006 440 237-241 10.1038/nature04516 16407889
7. Martinon F Tschopp J Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases Cell 2004 117 561-574 10.1016/j.cell.2004.05.004 15163405
8. Martinon F Tschopp J NLRs join TLRs as innate sensors of pathogens Trends Immunol 2005 26 447-454 10.1016/j.it.2005.06.004 15967716
9. Kanneganti TD Ozoren N Body-Malapel M Amer A Park JH Franchi L Whitfield J Barchet W Colonna M Vandenabeele P Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 Nature 2006 440 233-236 10.1038/nature04517 16407888
10. Mariathasan S Weiss DS Newton K McBride J O'Rourke K Roose-Girma M Lee WP Weinrauch Y Monack DM Dixit VM Cryopyrin activates the inflammasome in response to toxins and ATP Nature 2006 440 228-232 10.1038/ nature04515 16407890
11. Agostini L Martinon F Burns K McDermott MF Hawkins PN Tschopp J NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder Immunity 2004 20 319-325 10.1016/ S1074-7613(04)00046-9 15030775
12. Hawkins PN Lachmann HJ Aganna E McDermott MF Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra Arthritis Rheum 2004 50 607-612 10.1002/art.20033 14872505
13. Goldbach-Mansky R Dailey NJ Canna SW Gelabert A Jones J Rubin BI Kim HJ Brewer C Zalewski C Wiggs E Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition N Engl J Med 2006 355 581-592 10.1056/NEJMoa055137 16899778
14. Ortiz-Bravo E Schumacher HR Jr Components generated locally as well as serum alter the phlogistic effect of monosodium urate crystals in vivo J Rheumatol 1993 20 1162-1166 8371210
15. Wallace SL Robinson H Masi AT Decker JL McCarty DJ Yu TF Preliminary criteria for the classification of the acute arthritis of primary gout Arthritis Rheum 1977 20 895-900 10.1002/art.1780200320 856219
16. Chapman PT Yarwood H Harrison AA Stocker CJ Jamar F Gundel RH Peters AM Haskard DO Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: In vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1 Arthritis Rheum 1997 40 955-965 10.1002/art.1780400525 9153559
17. Terkeltaub R Zachariae C Santoro D Martin J Peveri P Matsushima K Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation Arthritis Rheum 1991 34 894-903 10.1002/art.1780340716 2059236